Isthmus Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
290
+25
+9% +$25.5K 0.03% 185
2026
Q1
$244K Sell
265
-10
-4% -$10.1K 0.03% 204
2025
Q4
$296K Buy
+275
New +$263K 0.03% 180

Other funds holding LLY

Isthmus Partners's LLY Position: Q2 2026 in Review

Isthmus Partners increased its Eli Lilly (LLY) stake by 9.4% in Q2 2026, buying an estimated $25.5K and bringing the position to 290 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #185.

Isthmus Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Isthmus Partners held 290 shares of Eli Lilly worth $348K as of Q2 2026.
  • Isthmus Partners bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.03% of Isthmus Partners's portfolio in Q2 2026, its #185 holding.
  • Isthmus Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.